Montelukast sodium qualitest
Some medicines may affect how montelukast sodium works, or montelukast sodium may affect how your other medicines work. The safety profile of montelukast sodium, when administered as a single dose for prevention of EIB in pediatric patients 6 years of age and older, was consistent with the safety profile previously described for montelukast sodium.
Patients with both asthma and allergic rhinitis should take only one montelukast sodium dose daily in the evening.
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. It may harm them. Due to inconsistencies between the drug labels on DailyMed and the pill images provided by RxImagewe no longer display the RxImage pill images associated with drug labels.
Growth Rate in Pediatric Patients A week, multi-center, double-blind, randomized, active- and placebo-controlled parallel group study was conducted to assess the effect of montelukast sodium on growth rate in patients with mild asthma, aged 6 to 8 years.
Prevent exercise-induced asthma in people 6 years of age and older.
Images for E225
Studies in rats have shown that montelukast is excreted in milk. The median age was Post-marketing reports with montelukast sodium use include agitation, aggressive behavior or hostility, anxiousness, depression, disorientation, disturbance in attention, dream abnormalities, hallucinations, insomnia, irritability, memory impairment, restlessness, somnambulism, suicidal thinking and behavior including suicideand tremor.
The clinical details of some post-marketing reports involving montelukast sodium appear consistent with a drug-induced effect. The film coating contains: Print this page Add to My Med List.
Efficacy was demonstrated for seasonal allergic rhinitis when montelukast was administered in the morning or the evening without regard to time of food ingestion. Patients already taking montelukast sodium daily for another indication including chronic asthma should not take an additional dose to prevent EIB. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
The effect of montelukast sodium on eosinophils in the peripheral blood was examined in clinical trials. The safety of montelukast sodium 4-mg and 5-mg chewable tablets in pediatric patients aged 2 to 14 years with allergic rhinitis is supported by data from studies conducted in pediatric patients aged 2 to 14 years with asthma. Patients should be instructed to notify their prescriber if these changes occur. Montelukast sodium has been evaluated for safety in adult and adolescent patients 15 years of age and older with perennial allergic rhinitis of whom received montelukast sodium in two, 6-week, clinical studies.
With prolonged treatment, the adverse experience profile did not significantly change. Patients with asthma on therapy with montelukast sodium may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg-Strauss syndrome, a condition which is often treated with systemic corticosteroid therapy.
The two studies enrolled a total of patients, of whom received montelukast sodium mg tablets. Patients already taking 1 tablet daily for another indication shouldn't take an additional dose. Take advantage of the world's leading distribution platform. Daily administration of montelukast sodium for the chronic treatment of asthma has not been established to prevent acute episodes of EIB. Blocks action of leukotrienes, decreasing smooth muscle contractions and edema in bronchial airways and preventing inflammation and bronchospasm.
Some medicines may affect how montelukast sodium works, or montelukast sodium may affect how your other medicines work.